Zenufa Laboratories Limited

Tanzania Health

Zenufa is the second largest manufacturer of pharmaceutical generics in Tanzania. The company was established in 1995 as an importer of pharmaceutical brands.

We are invested in Zenufa Laboratories Limited through Catalyst Fund I, which is managed by Catalyst Principal Partners. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts


Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

Africa, East Africa

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

Intermediated investment
Catalyst Fund I
Fund Manager:
Catalyst Principal Partners
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

August 2016

This is the investee company’s place of incorporation; or a fund’s jurisdiction.